Dealings in Securities by Directors, Prescribed Officers and the Company Secretary of the Company
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
“the Company”
DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF THE
COMPANY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:
DIRECTORS OF THE COMPANY
Director : Stephen Bradley Saad
Date of transaction : 22 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 24 426
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R4 562 212.56
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Sean Matthew Capazorio
Date of transaction : 22 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 15 546
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R2 903 633.69
Nature of interest : Direct beneficial
Clearance obtained : Yes
PRESCRIBED OFFICERS OF THE COMPANY
Prescribed Officer : Michael Guy Attridge
Date of transaction : 23 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 10 558
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R1 971 990.51
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Lorraine Angela Hill
Date of transaction : 26 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 12 236
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R2 285 402.15
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Zizipho Mmango
Date of transaction : 22 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 11 728
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R2 190 519.48
Nature of interest : Direct beneficial
Clearance obtained : Yes
PRESCRIBED OFFICER AND COMPANY SECRETARY OF THE COMPANY
Prescribed Officer & Company Secretary : Reginald Haman
Date of transaction : 22 September 2023
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 11 728
Class of securities : Ordinary shares
Grant price : R186.7769
Value of Transaction : R2 190 519.48
Nature of interest : Direct beneficial
Clearance obtained : Yes
All acceptances of deferred bonus shares are deemed to be off-market trades.
Durban
27 September 2023
Sponsor
Investec Bank Limited
Date: 27-09-2023 11:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.